Home › Funds › Empery Asset Management, LP › DTIL
Empery Asset Management, LP position in DTIL
PRECISION BIOSCIENCES INC · Health Care
Empery Asset Management, LP reported holding 776,093 shares of DTIL (PRECISION BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 7.05% of its reported portfolio and ranking #4 among its reported holdings. Empery Asset Management, LP has disclosed DTIL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Empery Asset Management, LP's DTIL position evolved
Empery Asset Management, LP first disclosed a stake in DTIL in Q4 2025 at 2,194,635 shares (US$9.1M). The position peaked in Q1 2026 at 1,968,879 shares, worth US$10.8M. Across 3 filings, Empery Asset Management, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 776,093 shares valued at US$6.1M — a reduction of -1,192,786 shares quarter over quarter.. Notable position changes include a 61% trim in Q2 2026 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.19M | $9.13M | New |
| Q1 2026 | 1.97M | $10.83M | Reduce |
| Q2 2026 | 776.09K | $6.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DTIL and 13F data
DTIL (PRECISION BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in DTIL — the largest reported positions include Bleichroeder LP (US$15.9M), Octagon Capital Advisors LP (US$10.6M), Lynx1 Capital Management LP (US$7.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DTIL
- Bleichroeder LP 2.02M sh · $15.86M · Q2 2026
- Octagon Capital Advisors LP 1.35M sh · $10.61M · Q2 2026
- Lynx1 Capital Management LP 950.47K sh · $7.47M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $314.40K · Q2 2026
More on Empery Asset Management, LP
FAQ
How long has Empery Asset Management, LP held DTIL?
Empery Asset Management, LP has disclosed DTIL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Empery Asset Management, LP's current position in DTIL?
As of Q2 2026, Empery Asset Management, LP holds 776.09K shares of DTIL (PRECISION BIOSCIENCES INC), valued at $6.10M, representing 7.05% of its reported portfolio and ranking #4.
Has Empery Asset Management, LP been buying or selling DTIL?
In the latest 13F filing (Q2 2026), Empery Asset Management, LP reduced its position in DTIL. The position peaked in Q1 2026 at 1.97M shares.
Which other funds hold DTIL?
Other major institutional holders of DTIL include Bleichroeder LP, Octagon Capital Advisors LP, Lynx1 Capital Management LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.